HLA alleles, blocks, and haplotypes associated with the hematological diseases of AML, ALL, MDS, and AA in the Han population of Southeastern China

HLA alleles, blocks, and haplotypes associated with the hematological diseases of AML, ALL, MDS, and AA in the Han population of Southeastern China

Saved in:

Bibliographic Details
Main Authors:	Yuxi Gong, Xue Jiang, Yuqian Zheng, Yang Li, Xiaojing Bao, Wenjuan Zhu, Ying Li, Xiaojin Wu, Bo Liang, Tengteng Zhang, Jun He, Sihan Zhou, Xiuyuan Hao
Format:	Article
Language:	English
Published:	Wolters Kluwer 2025-04-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000003521
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAML
by: Marcus Bauer, et al.
Published: (2024-12-01)

Recognition of HLA-DPB1 alleles and their associated HLA haplotypes in 55 randomized unrelated Taiwanese individuals
by: Shee-Ping Chen, et al.
Published: (2024-09-01)

Distribution of HLA-A, -B, and -C Alleles and HLA/KIR Combinations in Han Population in China
by: Yunsong Shen, et al.
Published: (2014-01-01)

A Multi-Well Method for the CD138 and AML/MDS FISH Testing of Multiple Biomarkers on a Single Slide in Multiple Myeloma and AML/MDS Patients
by: Frank Tambini, et al.
Published: (2025-06-01)

HLA Class II Allele, Haplotype, and Genotype Associations with Type 1 Diabetes in Benin: A Pilot Study
by: Kaossarath A. Fagbemi, et al.
Published: (2017-01-01)

Paclitaxel Induced MDS and AML: A Case Report and Literature Review
by: Udit Bhaskar Bhatnagar, et al.
Published: (2016-01-01)

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML
by: Petra Bašová, et al.
Published: (2025-01-01)

Association of the HLA-DQA1 and HLA-DQB1 Alleles in Type 2 Diabetes Mellitus and Diabetic Nephropathy in the Han Ethnicity of China
by: Ze-Jun Ma, et al.
Published: (2013-01-01)

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy
by: Christoforos K. Vaxevanis, et al.
Published: (2023-12-01)

HLA Polymorphisms and Haplotype Diversity in Transylvania, Romania
by: Mihaela L. Vică, et al.
Published: (2019-01-01)

PERFORMANCE OF CYTOGENETIC TESTS IN AML AND MDS SAMPLES PROCESSED IN A REMOTE LABORATORY IN BRAZIL
by: A Amaro, et al.
Published: (2024-10-01)

TP53-mutated MDS and AML: immune dysregulation, tumor microenvironment, and emerging therapeutic strategies
by: Marwah M. Albakri, et al.
Published: (2025-08-01)

A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML
by: Patricia L. Kropf, et al.
Published: (2025-05-01)

Comparison of HLA allelic imputation programs.
by: Jason H Karnes, et al.
Published: (2017-01-01)

Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT
by: Rongtao Xue, et al.
Published: (2025-02-01)

HLA Haplotypes and Genotypes Frequencies in Brazilian Chronic Periodontitis Patients
by: Emília Ângela Sippert, et al.
Published: (2015-01-01)

Exploration of Efficient HLA Haplotypes by Comparing the Proportion of Applicable Populations
by: Paeng Sunwoong, et al.
Published: (2024-10-01)

Impact of Decitabine Conditioning on Allo‐HSCT Outcomes in AML and Intermediate‐to‐High‐Risk MDS Patients in Remission
by: Shuling Yu, et al.
Published: (2025-07-01)

ANALYSIS OF GENETIC SEQUENCING DATA IN PATIENTS WITH AML AND MDS: WHAT IS ITS IMPACT ON BONE MARROW TRANSPLANTATION
by: CASA Dalva, et al.
Published: (2024-10-01)

HLA and leukemia: is it a simple allelic association?
by: M T Dorak, et al.
Published: (1992-01-01)

Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations
by: Yu Liu, et al.
Published: (2024-12-01)

Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
by: Sophia S Wang, et al.
Published: (2011-01-01)

The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS
by: Nanni Schmitt, et al.
Published: (2025-08-01)

Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab
by: Jan Philipp Bewersdorf, et al.
Published: (2025-06-01)

HLA-DRB1 alleles in patients with rheumatoid arthritis
by: L A Taukumova, et al.
Published: (2004-08-01)

An Increased Frequency in HLA Class I Alleles and Haplotypes Suggests Genetic Susceptibility to Influenza A (H1N1) 2009 Pandemic: A Case-Control Study
by: Ramcés Falfán-Valencia, et al.
Published: (2018-01-01)

HLA Haplotype Association with Celiac Disease in Albanian Pediatric Patients from Kosovo
by: Atifete Ramosaj-Morina, et al.
Published: (2019-01-01)

Association of HLA-C*07:359 with HLA-A, -B, and -DRB1 alleles in Taiwanese
by: Kuo-Liang Yang, et al.
Published: (2024-01-01)

Long‐term follow‐up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML
by: David A. Sallman, et al.
Published: (2025-07-01)

O-GlcNAcylated FTO promotes m6A modification of SOX4 to enhance MDS/AML cell proliferation
by: Junjie Gou, et al.
Published: (2025-01-01)

ASSOCIATION OF HLA HAPLOTYPES WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN CONDITIONS OF ORGANIC- SILICON MANUFACTURE
by: L. M. Karzakova, et al.
Published: (2019-05-01)

A new HLA susceptibility haplotype defined in three familial cases of frontal fibrosing alopecia
by: Ahmet Kağan Özdemir, et al.
Published: (2025-07-01)

Computational Immunogenetic Analysis of Botulinum Toxin A Immunogenicity and HLA Gene Haplotypes: New Insights
by: Eqram Rahman, et al.
Published: (2025-04-01)

Comparison between different reduced intensity conditioning regimens in AML/MDS patients in a Latin American center of adult stem cell transplantation
by: José Salinas, et al.
Published: (2024-12-01)

ERAP1 Gene Variants and Haplotypes Associated With Psoriasis Vulgaris of Han Chinese in Inner Mongolia
by: Xin Li, et al.
Published: (2024-11-01)

The INVOLVEMENT OF HLA-DRB1*11 AND HLA-DRB1*12 ALLELES IN THE OCCURRENCE OF DENGUE FEVER IN BURKINA FASO
by: Lassina TRAORE, et al.
Published: (2024-12-01)

Association between the HLA-A, HLA-B, HLA-C and HLA-DRB1 gene alleles and Sjögren's syndrome with anti-Ro/SSA and anti-La/SSB autoantibodies production
by: I. A. Guseva, et al.
Published: (2024-12-01)

Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association study
by: Elke Rücker-Braun, et al.
Published: (2025-06-01)

HLA-haplotypes and the risk of developing diabetes of type 1 diabetes in the native population of the Nenets Autonomous district
by: Tamara Leonidovna Kuraeva, et al.
Published: (2017-05-01)

Co-operative additive effects between HLA alleles in control of HIV-1.
by: Philippa C Matthews, et al.
Published: (2012-01-01)